Abstract
According to results of the Atorvastatin for Reduction of Myocardial Damage During Angioplasty-Acute Coronary Syndromes (ARMYDA-ACS) trial, short-term pretreatment with high-dose atorvastatin prior to percutaneous coronary intervention improves clinical outcome in subjects with unstable angina and non-ST-segment elevation myocardial infarction. These findings support the upstream administration of high-dose statins in subjects with acute coronary syndrome treated with an early invasive strategy.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 17-20 |
| Numero di pagine | 4 |
| Rivista | Cardiology Review |
| Volume | 24 |
| Numero di pubblicazione | 10 |
| Stato di pubblicazione | Pubblicato - ott 2007 |
| Pubblicato esternamente | Sì |